Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) tumbled nearly 17% this morning after investors learned that a Pernix and GSK had been in arbitration …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the appointment of Ken Piña as Senior Vice President, General Counsel and Chief Compliance Officer. Mr.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the appointment of Gabriel Leung to its Board of Directors, effective immediately. The Board also determined that …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced financial results for the three and nine months ended September 30, 2016. Third Quarter 2016 Financial and …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the appointment of Graham G. Miao, Ph.
By Dana Lyons A key gauge of biotechnology stocks is testing major trendline support presently – can it hold yet again? When this …
Shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) are down after the specialty pharma company initiated a reverse split of its common stock at a …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced the distribution of TREXIMET® (sumatriptan and naproxen sodium) 10/60 mg to wholesalers has begun. TREXIMET 10/60 mg …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that Marsha Stanton, Ph.D.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) announced that the United States Patent and Trademark Office has issued U.S.